$TLX (-4,7%)

In 2025, the Talanx Group increased its insurance sales by 5 percent at constant exchange rates to EUR 49.0 billion and consolidated net income by 25 percent to EUR 2,480 million, thus achieving the profit target, which was raised to more than EUR 2.4 billion in the course of the year.

The operating result (EBIT) rose to EUR 5.3 billion, the return on equity to 19.7%, and the Management Board and Supervisory Board are proposing a 33% increase in the dividend per share to EUR 3.60.

Highlights Sales growth: Insurance sales 2025 adjusted for currency effects +5% to EUR 49.0 billion (in euros +2%). :

Jump in consolidated profit +25% to EUR 2,480 million, above the original target of >EUR 2.1 billion and in line with the forecast, which has been raised to >EUR 2.4 billion.

Key operating figures: EBIT +8 percent to EUR 5.3 billion, underwriting result +11 percent to EUR 5.7 billion, return on equity 19.7 percent. :

Proposal to increase the dividend per share by 33% to EUR 3.60; dividend growth thus stronger than the Group result. :

Profit contribution All business divisions contribute to profit growth, primary insurance and reinsurance each make an equal contribution. :

Claims experience Despite the largest natural catastrophe loss in the Group's history in the first quarter, the Group benefited from an unusually low number of natural catastrophes in the following three quarters. :

Strategy Diversification, decentralization, cost leadership and a culture of trust are highlighted as key success factors.

Outlook2026: Confirmation of the profit target of around EUR 2.7 billion and expectation of a return on equity of around 19%; the target originally announced for 2027 should therefore be achieved and exceeded one year earlier. :

Risk information Targets are subject to stable currency and capital markets, expected major losses and a geopolitical and macroeconomic situation that does not escalate further.

Conclusion Talanx shows a very strong and high-quality result in 2025 with significant profit and dividend growth, supported by operational strength, good claims development and a broad, diversified positioning.

The optimistic outlook for 2026 with a targeted consolidated result of EUR 2.7 billion and a high return on equity underlines the ambition to even exceed the company's own medium-term planning, but remains dependent on market and claims developments as well as geopolitical risks.

$HNR1 (-4,1%)

@GREYxCAPITAL

The reinsurer Hannover Rück SE $HNR1 (-4,1%) achieved solid growth in the 2025 financial year despite high natural catastrophe losses. The operating result and profit in particular developed positively, while the dividend was increased significantly at the same time.

Gross premiums in the reinsurance business rose to EUR 26.8 billion in 2025, up around 1.5% on the previous year. The operating result (EBIT) increased by around 5.7% to 3.5 billion euros, while consolidated profit climbed to 2.64 billion euros - an increase of around 13% compared to 2024.

The combined ratio in the property and casualty business improved further to 84%, which is considered very profitable in the reinsurance market.

Hannover Re remains in an extremely solid financial position. The Solvency II ratio is 256%, well above the regulatory requirements. Equity continued to grow to around EUR 16.7 billion.

The company therefore has sufficient capital to absorb even major loss events or market volatility.

Dividend:

The dividend will be increased significantly. The Executive Board is proposing a total dividend of €12.50 per share for 2025. This includes an ordinary dividend of € 7 and a special dividend of € 5.50.

Hannover Re is thus continuing its shareholder-friendly dividend policy.

Challenges in the year 2025

The year was characterized by several major natural catastrophes, including above all losses from extreme weather events. Overall, the insured losses amounted to around EUR 20 billion.

Despite these burdens, profitability remained stable, underlining the Group's strong risk management.

Conclusion:

Hannover Re remains one of the most stable reinsurers worldwide.

The company impresses with:

constant profit growth

very high capital strength

attractive dividend policy

disciplined risk management

For long-term investors, the share therefore remains a defensive quality stock in the financial sector.

The DZ Bank analysts have drawn up two lists of shares that they consider to be particularly attractive. For more defensive investors and for investors who rely on continuous cash flows, they recommend the so-called "dividend aristocrats": In other words, companies that have regularly paid and raised dividends.

Top dividend aristocrats:

Pfizer $PFE (-1,6%), Verizon $VZ (+1,57%), BNP Paribas $BNP (-4,24%)Zurich Insurance $ZURN (-0,12%), Enel $ENEL (-2,39%), Sanofi $SAN (-1,3%), Hannover Re $HNR1 (-4,1%) , Man and Machine $MUM (-2,68%), Generali $G (-1,2%) and Allianz $ALV (-2,53%)

Another list has been compiled for investors with a somewhat higher risk appetite: Stocks with attractive dividend yields and additional share price potential. These not only pay a good dividend of at least three percent, but could also increase significantly in price in the future. However, the continuity of dividends in the past plays a lesser role - and this strategy is correspondingly riskier.

Top dividend rockets:

Man and machine $MUM (-2,68%) , Cancom $COK (-5,33%), Bastei Lübbe $BST (+0,15%), Sixt $SIX2 (-3,15%), Kontron $KTN (-3,47%), Fresenius Medical Care $FME (-1,88%), Vonovia $VNA (-2,35%), Hawesko $HAW (-0,62%), ElringKlinger $ZIL2 (+0,97%) and Hannover Re $HNR1 (-4,1%)

Source text (excerpt) & graphic: World | AAA, 19.02.2026

Hello everyone,

currently trying to take advantage of the market weakness for my portfolio.

I have added to the stocks $HNR1 (-4,1%)
$KRN (-3,58%)
$BC8 (-15,6%) on the German market. In my opinion, there are more opportunities than risks due to my long-term focus on growth/dividends.

I am currently continuing to explore the market for opportunities to make anti-cyclical purchases in my portfolio.

The healthcare and utilities sectors are still on my list for further purchases.

$EDP (-2,84%) and $ZTS (-0,18%) I find very interesting.

Do you have any current recommendations in these two areas? Companies that combine div. growth, yields of 2-4 percent and share price potential.

Thank you in advance for your contributions

I have also increased my position in Hannover Re $HNR1 (-4,1%) to 100 shares. The main reason for this is the "predictable, reliable" dividends combined with a very solid business model.

$HNR1 (-4,1%)

I recently invested in Hannover Rück SE because I consider the current share price level to be attractive in relation to the operating performance and dividend policy.

Hannover Re is one of the world's largest reinsurers and has been benefiting from a generally improved market environment for some time. Price discipline in the reinsurance market is high, while at the same time demand for reinsurance cover continues to rise. This is having a positive effect on margins and earnings quality.

I am currently particularly impressed by the company's dividend strategy. Following a very strong financial year, a significantly higher dividend has been announced. The combination of basic and special dividends leads to an attractive dividend yield without compromising the Group's capital strength. At the same time, Hannover Re pursues a clearly communicated dividend policy that is geared towards reliability and sustainability.

The company also has a solid balance sheet. The return on equity is well above the company's own targets, and the capitalization provides a sufficient buffer to absorb major losses or volatile years - an important point in the reinsurance industry.

All in all, I currently see Hannover Re as a solid, defensive portfolio component that can impress with both current income and long-term value stability. The entry is based on a long-term investment horizon and a focus on dividend continuity.

I would be interested to hear your current assessment of Hannover Re - especially in comparison with other reinsurers such as Munich Re or international competitors.

I started at €236 and think the price is very fair 😜

$ALV (-2,53%)
$HNR1 (-4,1%)
#versicherung
#dividende

Novo Nordisk 3.0% $NOVO B (-1,89%) NVO

LVMH 2.0% $LVMH

Pernod Ricard 6.35% $RI (-1,23%)

Imperial Brands 5.5% $IMB (-2,56%)

BAT 6.2% $BATS (-2,47%)

Sunrise Communications 8.00%

Nestle 4.05% $NESN (-0,79%)

Roche 2.85% $ROG

Novartis 3.07% $NOVN (-0,62%)

Shell 4.07% $SHEL (+0,46%)

German Post 3.86% $DHL (-3,55%)

Swisscom 3.75% $SCMN (-4,88%)

German Telekom 3.52% $DTE (-2,35%)

Strabag 2.72% $STR (-1,11%)

Vonovia 4.82% $VNA (-2,35%)

BASF 5.01% $BAS (-2,46%)

Puma 2.8% $PUMA

Hannover Re 3.62% $HNR1 (-4,1%)

Munich Re 3.8% $MUV2 (-2,16%)

Allianz 4.00% $ALV (-2,53%)

BP 5.76% $BP. (-3,01%)

Spotify

https://open.spotify.com/episode/1zt05UZlehInr81iaZMdY5?si=e676f0a812014943

YouTube

https://youtu.be/BpCIIJYfxHA

Appple Podcast

https://podcasts.apple.com/de/podcast/125-20-europ%C3%A4ische-dividenden-aktien/id1695869891?i=1000744769342

🔹 Hannover Re $HNR1 (-4,1%)

Strong reinsurer with a robust business model, reliable cash flows and an attractive dividend policy. For me, a defensive building block for portfolio stability.

🔹 Omada Health $OMDA (-3%)

Exciting health tech company with a focus on digital prevention and chronic diseases. Benefits from the digitalization megatrend in the healthcare sector and offers long-term growth potential.

Good mix of stability & growth for the start of the new year 🚀

🟢 🚀

$GOOGL (-1,49%) +11%

$MC (-1,94%) +4%

$HNR1 (-4,1%) +3,4%

$BRK.B (+0,08%) +3,7%

$8001 (-0,75%) +2%

🔴🛝

$BTC (-0,01%) -15%

$MSFT (-1,47%) -6%

@Tenbagger2024 I have now done it like this

Following a very strong business performance, Hannover Re has raised its profit forecast for 2025 to around EUR 2.6 billion. In the first nine months of the year, net profit rose by 7.7 percent to EUR 2.0 billion, while the return on equity of 22 percent was well above the target figure.

Property and casualty reinsurance in particular developed profitably: the combined ratio improved to 86 percent and major losses remained well below budget at EUR 1.18 billion. Life and health reinsurance also posted stable results, while investments achieved a return of 2.8 percent despite targeted loss realizations.

For 2026 Hannover Re expects a further increase in Group net income to at least EUR 2.7 billion and a return on investment of around 3.5 percent.

At the same time, the dividend policy was adjusted: In future, around 55 percent of net profit is to be distributed, with the aim of a stable or rising dividend. Overall, the reinsurer confirms its strong market position and is ideally positioned for further profitable growth.

$HNR1 (-4,1%)